Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2019

GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Novartis AG

Bristol-Myers Squibb Co

Pfizer Inc

Takeda Pharmaceutical Co Ltd

Teva Pharmaceutical Industries Ltd

Merck & Co Inc

F. Hoffmann-La Roche Ltd

Sanofi

Incyte ...

Novartis AG

Bristol-Myers Squibb Co

Pfizer Inc

Takeda Pharmaceutical Co Ltd

Teva Pharmaceutical Industries Ltd

Merck & Co Inc

F. Hoffmann-La Roche Ltd

Sanofi

Incyte Corp

Amgen Inc

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region ...

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials 17

Clinical Trials by Phase in G7 Countries 19

Clinical Trials in G7 Countries by Trial Status 20

Clinical Trials by E7 Countries: Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials 22

Clinical Trials by Phase in E7 Countries 24

Clinical Trials in E7 Countries by Trial Status 25

Clinical Trials by Phase 27

In Progress Trials by Phase 28

Clinical Trials by Trial Status 30

Clinical Trials by End Point Status 32

Subjects Recruited Over a Period of Time 33

Clinical Trials by Sponsor Type 34

Prominent Sponsors 35

Top Companies Participating in Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials 37

Prominent Drugs 39

Clinical Trial Profile Snapshots 41

Appendix 1259

Abbreviations 1259

Definitions 1259

Research Methodology 1260

Secondary Research 1260

About GlobalData 1261

Contact Us 1261

Disclaimer 1261

Source 1262

List of Tables

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Region, 2019* 8

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical ...

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Region, 2019* 8

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, North America, Top Countries, 2019* 14

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16

Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials, G7 Countries (%), 2019* 17

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials, E7 Countries (%), 2019* 22

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Phase, 2019* 27

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 28

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 30

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 32

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 33

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 34

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 35

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 37

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 39

List of Figures

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, ...

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16

Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials, G7 Countries (%), 2019* 17

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials, E7 Countries (%), 2019* 22

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Phase (%), 2019* 27

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 28

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 30

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 32

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 33

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 34

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 35

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 37

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 39

GlobalData Methodology 1260

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports